Constipation drug approved by FDA for irritable bowel syndrome
A pharmacist pours Truvada pills back into the bottle at Jack’s Pharmacy on November 23, 2010 in San Anselmo, California.
The US Food and Drug Administration approved a new drug on Thursday that treats certain types of irritable bowel syndrome in adults.
According to WebMD, Dr. Noel Lee and Dr. Arnold Wald of the University of Wisconsin said Linzess targets many of the symptoms of IBS with minimal side effects "nevertheless, it has proven effective in only a minority of patients."
But its popularity may come from the fact that it works with a "single daily dose."
More from GlobalPost: Obesity pill Qsymia gets FDA approval
The Wall Street Journal reported patients take a capsule once a day on an empty stomach before eating.
This is good news to some 63 million Americans who suffer from constipation and an estimated 15 million people diagnosed with IBS, according to the National Institutes of Health, the Journal reported.
According to the study's authors the pill's main side effect, not surprisingly, is diarrhea.
The story you just read is available for free because thousands of listeners and readers like you generously support our nonprofit newsroom. Every day, reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you: We need your support to ensure we can continue this work for another year.
Make a gift today, and you’ll get us one step closer to our goal of raising $25,000 by June 14. We need your help now more than ever!